Ted Slafsky

Important Operational Insights for Covered Entities Choosing to Access 340B ESP 340breport.com/?p=6149 Alas, after much deliberation, your covered entity has decided to submit data to 340B ESP. As you embark on this journey, you may be asking yourself: Now what?!? #340B

HRSA Sanctions Manufacturer for Not Issuing Refund for 340B Overcharges 340breport.com/hrsa-sanction… #340B

Arkansas Health System Asks State to Enforce its 340B Contract Pharmacy Law Against Novo Nordisk 340breport.com/arkansas-heal… #340B

CMS Defends Delayed Fix for Illegal Medicare Drug Payment Cuts for 340B Hospitals 340breport.com/cms-defends-d… #340B

340B Prime Vendor Sued for Allegedly Not Negotiating Sub-Ceiling Pricing on HIV/AIDS Drugs 340breport.com/340b-prime-ve… #340B

Two of Three Appeals Court Judges Question Government’s Stance That Drug Companies May Not Impose Conditions on 340B Sales 340breport.com/?p=8213 Two judges on a three-judge federal appeals court panel in Philadelphia today questioned whether the 340B statute forbids drug m...

Fake Lilly Twitter Account Tweets “Insulin Is Free Now,” Temporarily Wiping Billions From Company’s Stock Value 340breport.com/?p=8196 The havoc caused by Twitter’s new policy on user identity verification struck drug manufacturer Eli Lilly last week when a counterfeit acco...

340B Law Should Be Amended to Include Emergency-Use COVID-19 Drugs, Health Affairs Opinion Article Says 340breport.com/?p=8197 The 340B statute should be amended to extend discounts to emergency-use drugs to treat COVID-19 as a first step in rebuilding the COVID-19 safety n...

With Democrats Retaining Control of U.S. Senate, Expect New Leadership in Key Committee 340breport.com/?p=8198 Democrats will still control the U.S. Senate for the next two years, it became clear over the weekend, but control of the House has not yet been decided one week a...

Hospital Group Says Survey Shows Drug Companies’ 340B Contract Pharmacy Limits Are Harmful 340breport.com/?p=8199 Drug company actions to limit 340B pricing through contract and specialty pharmacies are harming 340B hospitals and their patients, according to a new American ...

Appeals Court To Hear Arguments Today in AstraZeneca, Novo Nordisk, and Sanofi’s 340B Contract Pharmacy Suits 340breport.com/?p=8200 A federal appeals court in Philadelphia is hearing arguments today in AstraZeneca, Novo Nordisk, and Sanofi’s 340B contract pharmacy lawsuits...

Miles Truesdell, 340Best Board Member 340breport.com/?p=8172 Miles, a New Jersey native, has decades of experience serving in leadership positions in non-profit health boards and is proud to provide guidance to the 340Best’s CEO Anula Courtis. #340B

Top 20 Moments in 340B’s History 340breport.com/?p=8083 To mark the 340B program’s 30th anniversary Friday, 340B Report Publisher and CEO Ted Slafsky devotes his latest column for Omnicell to a remembrance of 20 key moments “that have had the greatest impact on this very im...

Is There a Loophole That Might Let CMS Keep Paying Some Hospital Departments ASP Minus 22.5% for 340B Drugs? 340breport.com/?p=8085 There could be a loophole in Tuesday’s Medicare hospital outpatient payment final rule for 2023 that lets the government keep paying hospitals...

Hospital Group Blasts CMS for Delaying Redress for Illegal 340B Drug Payments Cuts 340breport.com/?p=8086 The federal government has had “more than adequate time to correct” its unlawful Medicare Part B payment cuts for hospitals’ 340B purchased drugs from 2018 through 2022...

Contract Pharmacies: An Integral 340B Component for 30 Years 340breport.com/?p=8003 On behalf of the safety net providers and pharmacies that Powers represents, we celebrate the anniversary of the 340B statute’s enactment – November 4, 1992.   A 30th anniversary is a huge m...

Health Care as a Human Right? Why Not? 340breport.com/?p=7889 Avita is reinforcing its commitment to reducing health inequities by broadening its impact beyond pharmacy services. Learn more here. #340B